NYSE: COO |
| Healthcare / Medical Devices & Instruments / USA |
323.49 | +15.78 | +5.13% | Vol 528.56K | 1Y Perf -21.22% |
Jun 24th, 2022 16:03 DELAYED |
BID | 297.76 | ASK | 516.09 | ||
Open | 311.32 | Previous Close | 323.49 | ||
Pre-Market | - | After-Market | 323.49 | ||
- - | - -% |
Target Price | 409.50 | Analyst Rating | Strong Buy 1.50 | |
Potential % | 26.59 | Finscreener Ranking | ★+ 43.32 | |
Insiders Trans % 3/6/12 mo. | -100/-100/-100 | Value Ranking | ★★ 45.63 | |
Insiders Value % 3/6/12 mo. | -100/-100/-100 | Growth Ranking | ★★★+ 56.11 | |
Insiders Shares Cnt. % 3/6/12 mo. | -100/-100/-100 | Income Ranking | + 28.08 | |
Price Range Ratio 52W % | 15.73 | Earnings Rating | Sell | |
Market Cap | 15.96B | Earnings Date | 2nd Jun 2022 | |
Alpha | 0.00 | Standard Deviation | 0.07 | |
Beta | 0.90 |
Today's Price Range 308.71323.81 | 52W Range 297.34463.59 | 5 Year PE Ratio Range 25.30123.90 |
Summary:
Sell
Technical Indicators: | Neutral |
Moving Averages: | Strong Sell |
Performance | |||
---|---|---|---|
1 Week | 6.08% | ||
1 Month | -4.81% | ||
3 Months | -20.79% | ||
6 Months | -21.33% | ||
1 Year | -21.22% | ||
3 Years | -1.66% | ||
5 Years | 31.40% | ||
10 Years | 311.70% |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | 20.27 | |||
ROE last 12 Months | 14.03 | |||
ROA (5Y Avg) | 6.78 | |||
ROA last 12 Months | 8.91 | |||
ROC (5Y Avg) | 5.96 | |||
ROC last 12 Months | 10.32 | |||
Return on invested Capital Q | 1.29 | |||
Return on invested Capital Y | 1.32 | |||
Assets Turnover | 0.30 | |||
Receivables Turnover | 6.20 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
16.10 | ||||
2.15 | ||||
4.79 | ||||
21.80 | ||||
-12.90 | ||||
13.96 | ||||
10.85 | ||||
142.16 | ||||
18.16B | ||||
Forward PE | 20.32 | |||
PEG | 1.46 |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
0.60 | ||||
1.10 | ||||
0.27 | ||||
0.50 | ||||
18.90 | ||||
Leverage Ratio | 1.50 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
65.90 | ||||
16.90 | ||||
27.40 | ||||
15.30 | ||||
27.91 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
3.14B | ||||
63.63 | ||||
4.91 | ||||
6.63 |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
0.02 | ||||
0.06 | ||||
0.00 | ||||
0.00 | ||||
Payout ratio | 1.00 |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q02 2022 | 3.41 | 3.24 | -4.99 |
Q01 2022 | 3.08 | 3.24 | 5.19 |
Q04 2021 | 3.37 | 3.28 | -2.67 |
Q03 2021 | 3.30 | 3.41 | 3.33 |
Q02 2021 | 3.12 | 3.38 | 8.33 |
Q01 2021 | 2.77 | 3.17 | 14.44 |
Q04 2020 | 3.11 | 3.16 | 1.61 |
Q03 2020 | 1.58 | 2.28 | 44.30 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
7/2022 QR | 3.25 | -11.44 | Negative |
10/2022 QR | 3.46 | -6.99 | Negative |
10/2022 FY | 13.19 | -6.25 | Negative |
10/2023 FY | 15.00 | -6.31 | Negative |
Next Report Date | - |
Estimated EPS Next Report | 3.41 |
Estimates Count | 7 |
EPS Growth Next 5 Years % | 11.00 |
Volume Overview | |
---|---|
Volume | 528.56K |
Shares Outstanding | 49.34K |
Shares Float | 43.52M |
Trades Count | 14.28K |
Dollar Volume | 169.32M |
Avg. Volume | 383.05K |
Avg. Weekly Volume | 427.88K |
Avg. Monthly Volume | 392.89K |
Avg. Quarterly Volume | 328.38K |
The Cooper Companies Inc. (NYSE: COO) stock closed at 323.49 per share at the end of the most recent trading day (a 5.13% change compared to the prior day closing price) with a volume of 528.56K shares and market capitalization of 15.96B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 12000 people. The Cooper Companies Inc. CEO is Albert G. White.
The one-year performance of The Cooper Companies Inc. stock is -21.22%, while year-to-date (YTD) performance is -22.78%. COO stock has a five-year performance of 31.4%. Its 52-week range is between 297.34 and 463.59, which gives COO stock a 52-week price range ratio of 15.73%
The Cooper Companies Inc. currently has a PE ratio of 16.10, a price-to-book (PB) ratio of 2.15, a price-to-sale (PS) ratio of 4.79, a price to cashflow ratio of 21.80, a PEG ratio of 2.32, a ROA of 8.91%, a ROC of 10.32% and a ROE of 14.03%. The company’s profit margin is 27.91%, its EBITDA margin is 27.40%, and its revenue ttm is $3.14 Billion , which makes it $63.63 revenue per share.
Of the last four earnings reports from The Cooper Companies Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $3.41 for the next earnings report. The Cooper Companies Inc.’s next earnings report date is -.
The consensus rating of Wall Street analysts for The Cooper Companies Inc. is Strong Buy (1.5), with a target price of $409.5, which is +26.59% compared to the current price. The earnings rating for The Cooper Companies Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
The Cooper Companies Inc. has a dividend yield of 0.02% with a dividend per share of $0.06 and a payout ratio of 1.00%.
The Cooper Companies Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 10.33, ATR14 : 9.92, CCI20 : -42.31, Chaikin Money Flow : 0.07, MACD : -11.18, Money Flow Index : 34.44, ROC : -6.91, RSI : 46.23, STOCH (14,3) : 51.04, STOCH RSI : 1.00, UO : 49.92, Williams %R : -48.96), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of The Cooper Companies Inc. in the last 12-months were: Agostino Ricupati (Option Excercise at a value of $1 242 267), Agostino Ricupati (Sold 5 607 shares of value $2 363 411 ), Brian G. Andrews (Option Excercise at a value of $703 829), Brian G. Andrews (Sold 4 963 shares of value $2 248 830 ), Colleen E. Jay (Option Excercise at a value of $0), Daniel G. McBride (Option Excercise at a value of $9 919 556), Daniel G. McBride (Sold 72 624 shares of value $32 690 354 ), Gary S. Petersmeyer (Option Excercise at a value of $290 466), Gary S. Petersmeyer (Sold 2 955 shares of value $1 282 206 ), Holly R. Sheffield (Option Excercise at a value of $0), Jody S. Lindell (Option Excercise at a value of $443 025), Jody S. Lindell (Sold 5 200 shares of value $2 119 647 ), Maria Rivas (Option Excercise at a value of $0), Mark J. Drury (Option Excercise at a value of $0), Robert S. Weiss (Option Excercise at a value of $2 115 969), Robert S. Weiss (Sold 13 039 shares of value $5 414 368 ), Teresa S. Madden (Option Excercise at a value of $0), William A. Kozy (Option Excercise at a value of $0)
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | Strong Buy | Strong Buy | Strong Buy |
Cooper Companies operates two units: CooperVision and CooperSurgical. Accounting for approximately 75% of total sales, CooperVision is the the second-largest player in the oligopolistic contact lens market. Over 50% of CooperVision's sales are in international territories. The second unit, CooperSurgical, develops and manufactures diagnostic and surgical products for gynecologists and obstetricians, including the Paragard IUD, which Cooper acquired from Teva in 2017.
CEO: Albert G. White
Telephone: +1 925 460-3600
Address: 6101 Bollinger Canyon Road, San Ramon 94583, CA, US
Number of employees: 12 000
Mon, 20 Jun 2022 02:05 GMT Cooper Co (COO) Receives a Buy from Stifel Nicolaus
- TipRanks. All rights reserved.Fri, 03 Jun 2022 11:45 GMT Analysts Conflicted on These Healthcare Names: Cooper Co (COO) and Centessa Pharmaceuticals (CNTA)
- TipRanks. All rights reserved.Wed, 01 Jun 2022 12:05 GMT Cooper Co (COO) Receives a Hold from J.P. Morgan
- TipRanks. All rights reserved.Tue, 31 May 2022 11:45 GMT Analysts Opinions Are Mixed on These Healthcare Stocks: Cooper Co (COO) and Verrica Pharmaceuticals (VRCA)
- TipRanks. All rights reserved.Fri, 08 Apr 2022 09:35 GMT Cooper Co (COO) Initiated with a Hold at Needham
- TipRanks. All rights reserved.Fri, 04 Mar 2022 12:10 GMT Analysts Opinions Are Mixed on These Healthcare Stocks: Cooper Co (COO), Cytokinetics (CYTK) and Singular Genomics Systems (OMIC)
- TipRanks. All rights reserved.Fri, 04 Mar 2022 11:47 GMT Cooper Posts Better-Than-Expected Q1 Results
- TipRanks. All rights reserved.Fri, 18 Feb 2022 14:20 GMT The Cooper Companies: Strong Results, Attractive Valuation
- TipRanks. All rights reserved.Tue, 11 Jan 2022 09:29 GMT Rivians 2021 Production Misses Estimates, COO Steps Down Report
- TipRanks. All rights reserved.Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. CBOE EDGX Top real-time data for Premium users, NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Technology and data provided by TeleTrader. Conditions of Use. The regulations of the respective stock are to be observed. Copyright © 2022. All market data is provided by Quotemedia.com. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer. The Cryptocurrency Market real-time data provided by Cryptocompare.com
eToro USA LLC does not offer CFDs and makes no representation and assumes no liability as to the accuracy or completeness of the content of this publication, which has been prepared by our partner utilizing publicly available non-entity specific information about eToro. Your capital is at risk.
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.